India's Pharmaceutical Exports

Country Profile

Myanmar

Myanmar is a major destination for Indian pharmaceutical exports — $215M in FY 2025–26. Medicines accounts for 94% of shipments, with vaccines contributing $5.22M. The compound annual growth rate since FY2015 stands at 3.1%.

🇲🇲 #25 Destination · $215M · 1.4× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$215M
Exports FY2025–26 DGCIS
1.4×
Growth FY2015→2026
0.7%
Share of India Total
#25
Rank Among 178 Markets
3.1%
CAGR FY2015→2026
Myanmar is a major destination for Indian pharmaceutical exports — $215M in FY 2025–26. Medicines accounts for 94% of shipments, with vaccines contributing $5.22M. The compound annual growth rate since FY2015 stands at 3.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $203M (94.4%) Vaccines $5.22M (2.4%) Medicine Ingredients $4.95M (2.3%) Surgical & Hospital Supplies $1.31M (0.6%) Traditional & Herbal $676K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Myanmar in the RBI overseas direct investment dataset (2011–2026).